The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...

Inflammatory bowel disease (IBD) is a term that encompasses two chronic diseases of the gastrointestinal tract—ulcerative colitis and Crohn's disease. Symptoms of both forms of IBD overlap and include ...

A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the ...

The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Now, a study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in the next five ...

“Furthermore, these data strongly encourage us to pursue phase 2 clinical trials in other inflammatory indications including Crohn’s disease.” Ulcerative colitis is a debilitating ...

A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...